$2.93
2.66% today
Nasdaq, Feb 05, 04:16 pm CET
ISIN
US14161W1053
Symbol
CDLX

Cardlytics, Inc. Stock price

$3.01
-0.48 13.75% 1M
-4.09 57.58% 6M
-0.70 18.87% YTD
-3.92 56.57% 1Y
-64.48 95.54% 3Y
-83.56 96.52% 5Y
-10.36 77.49% 10Y
Nasdaq, Closing price Tue, Feb 04 2025
+0.09 3.08%
ISIN
US14161W1053
Symbol
CDLX

Key metrics

Market capitalization $152.98m
Enterprise Value $307.92m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.05
P/S ratio (TTM) P/S ratio 0.52
P/B ratio (TTM) P/B ratio 2.17
Revenue growth (TTM) Revenue growth -3.00%
Revenue (TTM) Revenue $293.47m
EBIT (operating result TTM) EBIT $-63.05m
Free Cash Flow (TTM) Free Cash Flow $-10.58m
Cash position $66.99m
EPS (TTM) EPS $-6.11
P/E forward negative
P/S forward 0.57
EV/Sales forward 1.15
Short interest 18.50%
Show more

Is Cardlytics, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,821 stocks worldwide.

Cardlytics, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Cardlytics, Inc. forecast:

5x Hold
83%
1x Sell
17%

Analyst Opinions

6 Analysts have issued a Cardlytics, Inc. forecast:

Hold
83%
Sell
17%

Financial data from Cardlytics, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
293 293
3% 3%
100%
- Direct Costs 163 163
8% 8%
55%
131 131
5% 5%
45%
- Selling and Administrative Expenses 113 113
7% 7%
39%
- Research and Development Expense 52 52
3% 3%
18%
-35 -35
31% 31%
-12%
- Depreciation and Amortization 28 28
7% 7%
10%
EBIT (Operating Income) EBIT -63 -63
22% 22%
-21%
Net Profit -275 -275
33% 33%
-94%

In millions USD.

Don't miss a Thing! We will send you all news about Cardlytics, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Cardlytics, Inc. Stock News

Neutral
Accesswire
about 16 hours ago
CDLX Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO, CA / ACCESS Newswire / February 4, 2025 / Cardlytics, the advertising technology company that connects marketers with consumers through their banking apps, is facing a class-action lawsuit alleging that it misled investors about its growth prospects. Hagens Berman urges Cardlytics, Inc. (NASDAQ:CDLX) investors who suffered...
Neutral
GlobeNewsWire
about 24 hours ago
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Cardlytics To Contact Him Directly To Discuss Their Options
Neutral
GlobeNewsWire
2 days ago
NEW YORK, Feb. 03, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Cardlytics, Inc. (NASDAQ: CDLX).
More Cardlytics, Inc. News

Company Profile

Cardlytics, Inc. engages in the development of marketing solutions through its purchase intelligence platform. It operates through the Cardlytics Direct and Other Platform Solutions segments. The Cardlytics Direct segment represents its proprietary native bank advertising channel. The Other Platform Solutions segment includes solutions that enable marketers and marketing service providers to leverage the power of purchase intelligence outside the banking channel. The company was founded by Scott D. Grimes, Lynne M. Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA.

Head office United States
CEO Amit Gupta
Employees 434
Founded 2008
Website www.cardlytics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today